Metal Drugs and the Anticancer Immune Response
Open accessThe DOI matches its Crossref record; 1,300 of the 1,300 references it cites were found in a registry or an index.
Abstract
The immune system deploys a multitude of innate and adaptive mechanisms not only to ward off pathogens but also to prevent malignant transformation ("immune surveillance"). Hence, a clinically apparent tumor already reflects selection for those malignant cell clones capable of evading immune recognition ("immune evasion"). Metal drugs, besides their well-investigated cytotoxic anticancer effects, massively interact with the cancer-immune interface and can reverse important aspects of immune evasion. This topic has recently gained intense attention based on combination approaches with anticancer immunotherapy (e.g., immune checkpoint inhibitors), a strategy recently delivering first exciting results in clinical settings. This review summarizes the promising but still extremely fragmentary knowledge on the interplay of metal drugs with the fidelity of anticancer immune responses but also their role in adverse effects. It highlights that, at least in some cases, metal drugs can induce long-lasting anticancer immune responses. Important steps in this process comprise altered visibility and susceptibility of cancer cells toward innate and adaptive immunity, as well as direct impacts on immune cell populations and the tumor microenvironment. On the basis of the gathered information, we suggest initiating joint multidisciplinary programs to implement comprehensive immune analyses into strategies to develop novel and smart anticancer metal compounds.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
2 retracted
Items 601–800 of 1,300
Multiple Mechanisms of Immune Suppression by B Lymphocytes
Klinker, M. W., & Lundy, S. K. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00333 · Cited by 132
DiLillo, D. J., & Ravetch, J. V. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0120 · Cited by 132
An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin
Meier, S. M., Kreutz, D., Winter, L., Klose, M. H. M., Cseh, K., Weiss, T., Bileck, A., Alte, B., Mader, J. C., Jana, S., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201702242 · Cited by 132
Self-citationManegold, C., van Zandwijk, N., Szczęsna, A., Zatloukal, P., Au, J. S. K., Błasińska-Morawiec, M., Serwatowski, P., Krzakowski, M. J., Jassem, J., Tan, E. H., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr030 · Cited by 130
Houghton, J. A. (1999) · Current Opinion in Oncology · doi:10.1097/00001622-199911000-00008 · Cited by 128
Wilson, C., Purcell, C., Seaton, A., Oladipo, O., Maxwell, P. J., O’Sullivan, J. M., Wilson, R. H., Johnston, P. G., & Waugh, D. J. J. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143826 · Cited by 127
Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF
Li, S., Gokden, N., Okusa, M. D., Bhatt, R., & Portilla, D. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00038.2005 · Cited by 126
Testicular germ cell tumors: pathogenesis, diagnosis and treatment
Winter, C., & Albers, P. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.196 · Cited by 125
Auranofin blocks interleukin‐6 signalling by inhibiting phosphorylation of JAK1 and STAT3
Kim, N.-H., Lee, M.-Y., Park, S.-J., Choi, J.-S., Oh, M.-K., & Kim, I.-S. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02679.x · Cited by 125
Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance
Zingoni, A., Fionda, C., Borrelli, C., Cippitelli, M., Santoni, A., & Soriani, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01194 · Cited by 125
Guo, W., Zheng, W., Luo, Q., Li, X., Zhao, Y., Xiong, S., & Wang, F. (2013) · Inorganic Chemistry · doi:10.1021/ic4002626 · Cited by 125
Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development
Valdés-Rives, S. A., & González‐Arenas, A. (2017) · Mediators of Inflammation · doi:10.1155/2017/9173090 · Cited by 125
Chrysotherapy: a synoptic review
Eisler, R. (2003) · Inflammation Research · doi:10.1007/s00011-003-1208-2 · Cited by 123
Heterometallic titanium–gold complexes inhibit renal cancer cells in vitro and in vivo
Fernández‐Gallardo, J., Elie, B. T., Sadhukha, T., Prabha, S., Sanaú, M., Rotenberg, S. A., Ramos, J. W., & Contel, M. (2015) · Chemical Science · doi:10.1039/c5sc01753j · Cited by 123
Gut microbiome and anticancer immune response: really hot Sh*t!
Viaud, S., Daillère, R., Boneca, I. G., Lepage, P., Langella, P., Chamaillard, M., Pittet, M. J., Ghiringhelli, F., Trinchieri, G., Goldszmid, R., et al. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.56 · Cited by 123
Transcription Factor NF-κB: An Update on Intervention Strategies
Panday, A., Inda, M. E., Bagam, P., Sahoo, M. K., Osorio, D., & Batra, S. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0405-y · Cited by 123
Regulatory T‐cell heterogeneity and the cancer immune response
Ward‐Hartstonge, K. A., & Kemp, R. A. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2017.43 · Cited by 122
Wang, N., Wang, Z., Xu, Z., Chen, X., & Zhu, G. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201800422 · Cited by 122
Bhattacharjee, A., Chakraborty, K., & Shukla, A. (2017) · Metallomics · doi:10.1039/c7mt00066a · Cited by 121
PD-1/PD-L1 pathway inhibitors in advanced prostate cancer
Velho, P. I., & Antonarakis, E. S. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1464388 · Cited by 121
Ghrelin Prevents Cisplatin-Induced Mechanical Hyperalgesia and Cachexia
Garcia, J. M., Cata, J. P., Dougherty, P. M., & Smith, R. G. (2008) · Endocrinology · doi:10.1210/en.2007-0828 · Cited by 120
Immuno‐Chemotherapeutic Platinum(IV) Prodrugs of Cisplatin as Multimodal Anticancer Agents
Wong, D. Y. Q., Yeo, C. H. F., & Ang, W. H. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201402879 · Cited by 120
Ruthenium-based compounds and tumour growth control (review).
Sava, G., & Bergamo, A. (2000) · International Journal of Oncology · doi:10.3892/ijo.17.2.353 · Cited by 118
Sukkurwala, A. Q., Martins, I., Wang, Y., Schlemmer, F., Ruckenstuhl, C., Durchschlag, M., Michaud, M., Senovilla, L., Sistigu, A., Ma, Y., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.73 · Cited by 118
Metal complexes as structural templates for targeting proteins
Dörr, M., & Meggers, E. (2014) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.01.005 · Cited by 117
Lazzari, C., Karachaliou, N., Bulotta, A., Viganó, M., Mirabile, A., Brioschi, E., Santarpia, M., Gianni, L., Rosell, R., & Gregorc, V. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835918762094 · Cited by 117
Turning Tumors into Vaccines: Co-opting the Innate Immune System
van den Boorn, J. G., & Hartmann, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.011 · Cited by 116
Zeligs, K. P., Neuman, M. K., & Annunziata, C. M. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1374 · Cited by 116
Jiang, J., Xu, N., Wu, C., Deng, H., Lu, M., Li, M., Xu, B., Wu, J., Wang, R., Xu, J., et al. (2006) · PubMed · Cited by 115
Parker, C. C., Coleman, R. E., Sartor, O. A., Vogelzang, N. J., Bottomley, D., Heinrich, D. A., Helle, S. I., O’Sullivan, J. M., Fosså, S. D., Chodacki, A., et al. (2017) · European Urology · doi:10.1016/j.eururo.2017.06.021 · Cited by 115
Gifford, J. B., Huang, W., Zeleniak, A. E., Hindoyan, A. A., Wu, H., Donahue, T. R., & Hill, R. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0774 · Cited by 114
Vanadium carcinogenic, immunotoxic and neurotoxic effects: a review of in vitro studies
Zwolak, I. (2013) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2013.843110 · Cited by 113
Gonzalez-Aparicio, M., Alzuguren, P., Mauleon, I., Medina-Echeverz, J., Hervas-Stubbs, S., Mancheno, U., Berraondo, P., Crettaz, J., Gonzalez-Aseguinolaza, G., Prieto, J., et al. (2011) · Gut · doi:10.1136/gut.2010.211722 · Cited by 113
Borse, V., Aameri, R. F. H. A., Sheehan, K. E., Sheth, S., Kaur, T., Mukherjea, D., Tupal, S., Lowy, M. M., Ghosh, S., Dhukhwa, A., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.314 · Cited by 113
Formyl peptide receptors at the interface of inflammation, angiogenesis and tumor growth
Prevete, N., Liotti, F., Marone, G., Melillo, R. M., & de Paulis, A. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.09.017 · Cited by 112
C u/Z n superoxide dismutase plays a role in angiogenesis
Marikovsky, M., Nevo, N., Vadai, E., & Harris‐Cerruti, C. (2002) · International Journal of Cancer · doi:10.1002/ijc.1565 · Cited by 110
HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis
Hernandez, C., Huebener, P., Pradere, J.-P., Antoine, D. J., Friedman, R. A., & Schwabe, R. F. (2018) · Journal of Clinical Investigation · doi:10.1172/jci91786 · Cited by 110
Markasz, L., Stuber, G., Vanherberghen, B., Flaberg, E., Olah, E., Carbone, E., Eksborg, S., Klein, E., Skribek, H., & Szekely, L. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0358 · Cited by 110
Lysyl oxidase in cancer inhibition and metastasis
Johnston, K. A., & Lopez, K. M. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.006 · Cited by 110
DAMP-TLR-cytokine axis dictates the fate of tumor
Patidar, A., Selvaraj, S., Sarode, A. Y., Chauhan, P. S., Chattopadhyay, D., & Saha, B. (2017) · Cytokine · doi:10.1016/j.cyto.2017.10.004 · Cited by 109
Kaur, T., Borse, V., Sheth, S., Sheehan, K. E., Ghosh, S., Tupal, S., Jajoo, S., Mukherjea, D., Rybak, L. P., & Ramkumar, V. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3111-15.2016 · Cited by 109
IL233, A Novel IL-2 and IL-33 Hybrid Cytokine, Ameliorates Renal Injury
Stremska, M. E., Jose, S. K., Sabapathy, V., Huang, L., Bajwa, A., Kinsey, G. R., Sharma, P. R., Mohammad, S., Rosin, D. L., Okusa, M. D., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016121272 · Cited by 108
Chen, N., Wei, M., Sun, Y., Li, F., Pei, H., Li, X., Su, S., He, Y., Wang, L., Shi, J., et al. (2013) · Small · doi:10.1002/smll.201300903 · Cited by 107
Hou, G.-X., Liu, P.-P., Zhang, S., Yang, M., Liao, J., Yang, J., Hu, Y., Jiang, W.-Q., Wen, S., & Huang, P. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0159-4 · Cited by 107
Lila, A. S. A., Kizuki, S., Doi, Y., Suzuki, T., Ishida, T., & Kiwada, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.02.023 · Cited by 107
Jain, S., Cohen, J., Ward, M. M., Kornhauser, N., Chuang, E., Cigler, T., Moore, A. L., Donovan, D., Lam, C., Cobham, M., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds654 · Cited by 107
Autophagy in Neurodegenerative Diseases and Metal Neurotoxicity
Zhang, Z., Miah, M. R., Culbreth, M. E., & Aschner, M. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1844-x · Cited by 107
Liu, W., Molnár, M., Garnham, C., Benav, H., & Rask‐Andersen, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00223 · Cited by 107
PARK, S.-H. G., LEE, J. G., Berek, J. S., & HU, M. Y. C.-T. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2579 · Cited by 106
Wei, H., Zhao, L., Li, W., Fan, K., Qian, W., Hou, S., Wang, H., Dai, M., Hellstrom, I., Hellstrom, K. E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084927 · Cited by 106
Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells
Donkor, M. K., Lahue, E. E., Hoke, T. A., Shafer, L. R., Çoşkun, U., Solheim, J. C., Gülen, D., Bishay, J., & Talmadge, J. E. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.03.021 · Cited by 106
Frik, M., Martínez, A., Elie, B. T., Gonzalo, Ó., de Mingo, D. R., Sanaú, M., Sánchez‐Delgado, R. A., Sadhukha, T., Prabha, S., Ramos, J. W., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5012337 · Cited by 106
Luo, Y., Chihara, Y., Fujimoto, K., Sasahira, T., Kuwada, M., Fujiwara, R., Fujii, K., Ohmori, H., & Kuniyasu, H. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.09.016 · Cited by 105
Chemotherapy Broadens the Range of Tumor Antigens Seen by Cytotoxic CD8+ T Cells in Vivo
Jackaman, C., Majewski, D., Fox, S. A., Nowak, A. K., & Nelson, D. J. (2012) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-012-1307-4 · Cited by 105
Systemic Inflammation in Cachexia – Is Tumor Cytokine Expression Profile the Culprit?
de Matos-Neto, E. M., Lima, J. D. C. C., de Pereira, W. O., Figuerêdo, R. G., Riccardi, D. M. D. R., Radloff, K., das Neves, R. X., Camargo, R. G., Maximiano, L. F., Tokeshi, F., et al. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00629 · Cited by 105
Di Blasio, S., Wortel, I. M. N., van Bladel, D. A. G., de Vries, L. E., Duiveman-de Boer, T., Worah, K., de Haas, N., Buschow, S. I., de Vries, I. J. M., Figdor, C. G., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1192739 · Cited by 105
Nakaya, A., Sagawa, M., Muto, A., Uchida, H., Ikeda, Y., & Kizaki, M. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.05.011 · Cited by 105
Nowak, A. K., Cook, A., McDonnell, A. M., Millward, M., Creaney, J., Francis, R. J., Hasani, A., Segal, A., Musk, A. W., Turlach, B. A., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv387 · Cited by 104
Schuhmann, D., Kubicka-Muranyi, M., Mirtcheva, J., Günther, J., Kind, P., & Gleichmann, E. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.7.2132 · Cited by 103
Chaviara, A. T., Christidis, P. C., Papageorgiou, A., Chrysogelou, E., Hadjipavlou‐Litina, D., & Bolos, C. A. (2005) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2005.07.011 · Cited by 103
Endogenous IL-10 Attenuates Cisplatin Nephrotoxicity: Role of Dendritic Cells
Tadagavadi, R. K., & Reeves, W. B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000383 · Cited by 103
Bloy, N., Garcia, P., Laumont, C. M., Pitt, J. M., Sistigu, A., Stoll, G., Yamazaki, T., Bonneil, E., Buqué, A., Humeau, J., et al. (2017) · Immunological Reviews · doi:10.1111/imr.12582 · Cited by 103
Arsenic Exposure and Immunotoxicity: a Review Including the Possible Influence of Age and Sex
Ferrario, D., Gribaldo, L., & Härtung, T. (2016) · Current Environmental Health Reports · doi:10.1007/s40572-016-0082-3 · Cited by 103
Vogelzang, N. J., Coleman, R. E., Michalski, J. M., Nilsson, S. F., O’Sullivan, J. M., Parker, C. C., Widmark, A., Thuresson, M., Xu, L., Germino, J., et al. (2016) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2016.07.027 · Cited by 103
Zheng, J., Dai, C., Steyger, P. S., Kim, Y., Vass, Z., Ren, T., & Nuttall, A. L. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00919.2002 · Cited by 102
Basic principles of tumor-associated regulatory T cell biology
Savage, P. A., Malchow, S., & Leventhal, D. S. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.08.005 · Cited by 102
Immunogenic and Non-immunogenic Cell Death in the Tumor Microenvironment
Pitt, J. M., Kroemer, G., & Zitvogel, L. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67577-0_5 · Cited by 102
Engineered metal based nanoparticles and innate immunity
Petrarca, C., Clemente, E., Amato, V., Pedata, P., Sabbioni, E., Bernardini, G., Iavicoli, I., Cortese, S., Niu, Q., Otsuki, T., et al. (2015) · Clinical and Molecular Allergy · doi:10.1186/s12948-015-0020-1 · Cited by 101
Cisplatin-Induced Hair Cell Death Requires STAT1 and Is Attenuated by Epigallocatechin Gallate
Schmitt, N. C., Rubel, E. W., & Nathanson, N. M. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5842-08.2009 · Cited by 101
Recent development of transition metal complexes with in vivo antitumor activity
Liang, J., Zhong, H., Yang, G., Vellaisamy, K., Ma, D., & Leung, C. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.06.002 · Cited by 101
Kang, T. H., Mao, C.-P., Lee, S. Y., Chen, A., Lee, J.-H., Kim, T. W., Alvarez, R. D., Roden, R. B. S., Pardoll, D., Hung, C.-F., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4241 · Cited by 100
Fine, J. H., Chen, P., Mesci, A., Allan, D. S. J., Gasser, S., Raulet, D. H., & Carlyle, J. R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1316 · Cited by 100
Markers and function of human NK cells in normal and pathological conditions
del Zotto, G., Marcenaro, E., Vacca, P., Sivori, S., Pende, D., Chiesa, M. D., Moretta, F., Ingegnere, T., Mingari, M., Moretta, A., et al. (2017) · Cytometry. Part B, Clinical cytometry · doi:10.1002/cyto.b.21508 · Cited by 100
Bergmann‐Leitner, E. S., & Abrams, S. I. (2001) · Cancer Immunology Immunotherapy · doi:10.1007/s002620100229 · Cited by 100
Li, Y., Yin, J., Liu, Z., & Li, X. (2018) · IUBMB Life · doi:10.1002/iub.1722 · Cited by 100
Cao, G., Wang, J., Zheng, X., Wei, H., Tian, Z., & Sun, R. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.674010 · Cited by 99
Mukherjea, D., Jajoo, S., Sheehan, K. E., Kaur, T., Sheth, S., Bunch, J. R., Perro, C. A., Rybak, L. P., & Ramkumar, V. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3497 · Cited by 98
Hao, W., Zhang, W.-J., McMillen, T. S., LeBoeuf, R. C., & Frei, B. B. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.06.013 · Cited by 98
Modulation of Cancer-Specific Immune Responses by Amino Acid Degrading Enzymes
Timosenko, E., Hadjinicolaou, A. V., & Cerundolo, V. (2017) · Immunotherapy · doi:10.2217/imt-2016-0118 · Cited by 98
Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds
Selman, M., Rousso, C., Bergeron, A., Son, H. H., Krishnan, R., El-Sayes, N., Varette, O., Chen, A., Bœuf, F. L., Tzelepis, F., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.10.014 · Cited by 98
Copper at the Fungal Pathogen-Host Axis
García-Santamarina, S., & Thiele, D. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.649129 · Cited by 97
Chan, A. J., Alikhan, M. A., Odobasic, D., Gan, P., Khouri, M. B., Steinmetz, O. M., Mansell, A. S., Kitching, A. R., Holdsworth, S. R., & Summers, S. A. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.01.023 · Cited by 97
Systemic cobalt toxicity from total hip arthroplasties
Zywiel, M. G., Cherian, J. J., Banerjee, S., Cheung, A., Wong, F. S.-H., BUTANY, J. W., Gilbert, C. J., Overgaard, C. B., Syed, K., Jacobs, J. J., et al. (2016) · The Bone & Joint Journal · doi:10.1302/0301-620x.98b1.36712 · Cited by 97
Cellular zinc homeostasis modulates polarization of THP-1-derived macrophages
Dierichs, L., Kloubert, V., & Rink, L. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1491-2 · Cited by 97
Somatostatin gene expression in the thymus gland.
Fuller, P. J., & Verity, K. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.3.1015 · Cited by 96
Platinum-based chemotherapy: gastrointestinal immunomodulation and enteric nervous system toxicity
Stojanovska, V., Sakkal, S., & Nurgali, K. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00212.2014 · Cited by 96
Cruz, L. J., Rueda, F., Cordobilla, B., Simón‐Gracia, L., Hosta‐Rigau, L., Alberício, F., & Domingo, J. C. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100178k · Cited by 96
Adam, J., Louvet, E., Sourisseau, T., Dorvault, N., Bernard, M., Maingot, E., Faivre, L., Cassin-Kuo, M.-S., Boissier, E., Dessoliers, M.-C., et al. (2018) · ESMO Open · doi:10.1136/esmoopen-2017-000257 · Cited by 96
Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target
Klein, G. L., Petschow, B. W., Shaw, A. L., & Weaver, E. (2013) · Current Opinion in Supportive & Palliative Care · doi:10.1097/spc.0000000000000017 · Cited by 95
Survival Benefit With Radium-223 Dichloride in a Mouse Model of Breast Cancer Bone Metastasis
Suominen, M. I., Rissanen, J. P., Käkönen, R. S., Fagerlund, K. M., Alhoniemi, E. J., Mumberg, D., Ziegelbauer, K. B., Halleen, J. M., Käkönen, S.-M., & Scholz, A. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt116 · Cited by 95
Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4
Youn, H. S., Lee, J. Y., Saitoh, S. I., Miyake, K., & Hwang, D. H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.097 · Cited by 94
Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
Findlay, J. M., Castro-Giner, F., Makino, S., Rayner, E., Kartsonaki, C., Cross, W., Kovac, M., Ulahannan, D., Palles, C., Gillies, R. S., et al. (2016) · Nature Communications · doi:10.1038/ncomms11111 · Cited by 94
Novel copper complexes as potential proteasome inhibitors for cancer treatment
Zhang, Z., Wang, H., Yan, M., Wang, H., & Zhang, C. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.6022 · Cited by 94
Stabilities and Biological Activities of Vanadium Drugs: What is the Nature of the Active Species?
Levina, A., & Lay, P. A. (2017) · Chemistry - An Asian Journal · doi:10.1002/asia.201700463 · Cited by 94
Comparison of oxaliplatin‐ and curcumin‐mediated antiproliferative effects in colorectal cell lines
Howells, L. M., Mitra, A., & Manson, M. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22645 · Cited by 93
Naphthalimide gold(i) phosphine complexes as anticancer metallodrugs
Bagowski, C. P., You, Y., Scheffler, H., Vlecken, D. H. W., Schmitz, D. J., & Ott, I. (2009) · Dalton Transactions · doi:10.1039/b912378d · Cited by 93
Role of oxidative stress in oxaliplatin‐induced enteric neuropathy and colonic dysmotility in mice
McQuade, R. M., Carbone, S. E., Stojanovska, V., Rahman, A., Gwynne, R. M., Robinson, A. M., Goodman, C. A., Bornstein, J. C., & Nurgali, K. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13646 · Cited by 93
γδ T cells in cancer immunotherapy
Zou, C., Zhao, P., Xiao, Z., Han, X., Fu, F., & Fu, L. (2017) · Oncotarget · doi:10.18632/oncotarget.13051 · Cited by 93
Kinsey, G. R., Sharma, R., & Okusa, M. D. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013050502 · Cited by 93
NF-κB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs)
Kerbauy, D. M. B., Lesnikov, V., Abbasi, N., Seal, S., Scott, B., & Deeg, H. J. (2005) · Blood · doi:10.1182/blood-2005-04-1424 · Cited by 92
Austin, C., & Rendina, L. M. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.11.007 · Cited by 92
Li, S., Wu, P., Yarlagadda, P., Vadjunec, N. M., Proia, A. D., Harris, R. A., & Portilla, D. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00190.2003 · Cited by 92
Hu, L.-Y., Zhou, Y., Cui, W., Hu, X., Du, L., Mi, W., Chu, Y., Wu, G.-C., Wang, Y., & Mao‐Ying, Q. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.10.011 · Cited by 92
Taïeb, J., Moehler, M. H., Boku, N., Ajani, J. A., Ruiz, E. Y., Ryu, M., Guenther, S., Chand, V. K., & Bang, Y. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.04.004 · Cited by 92
Copper at the Front Line of the Host-Pathogen Battle
Festa, R. A., & Thiele, D. J. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002887 · Cited by 91
Dunham, S. U., & Lippard, S. J. (1997) · Biochemistry · doi:10.1021/bi9709452 · Cited by 91
Crump, M., Tu, D., Shepherd, L. E., Levine, M., Bramwell, V. H. C., & Pritchard, K. I. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.137 · Cited by 91
The blood labyrinthine barrier in the human normal and Meniere’s disease macula utricle
Ishiyama, G. P., López, I. A., Ishiyama, P., Vinters, H. V., & Ishiyama, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-00330-5 · Cited by 91
A Phase II Trial of Tetrathiomolybdate After Surgery for Malignant Mesothelioma: Final Results
Pass, H. I., Brewer, G. J., Dick, R., Carbone, M., & Merajver, S. D. (2008) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2008.03.016 · Cited by 90
The role of microbiota in cancer therapy
Perez-Chanona, E., & Trinchieri, G. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.01.003 · Cited by 90
van der Sluis, T. C., van Duikeren, S., Huppelschoten, S., Jordanova, E. S., Beyranvand Nejad, E., Sloots, A., Boon, L., Smit, V. T. H. B. M., Welters, M. J. P., Ossendorp, F., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2142 · Cited by 89
Li, J., Davidson, G., Huang, Y., Jiang, B., Shi, X., Costa, M., & Huang, C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0737 · Cited by 89
Microbiome mediation of infections in the cancer setting
Taur, Y., & Pamer, E. G. (2016) · Genome Medicine · doi:10.1186/s13073-016-0306-z · Cited by 89
Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition
Siefker-Radtke, A. O., & Curti, B. D. (2017) · Nature Reviews Urology · doi:10.1038/nrurol.2017.190 · Cited by 89
Nanoparticle‐Induced Exosomes Target Antigen‐Presenting Cells to Initiate Th1‐Type Immune Activation
Zhu, M., Tian, X., Song, X., Li, Y., Tian, Y., Zhao, Y., & Nie, G. (2012) · Small · doi:10.1002/smll.201200381 · Cited by 89
Pal, M., Nandi, U., & Mukherjee, D. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.03.015 · Cited by 89
Baj, G., Arnulfo, A., Deaglio, S., Mallone, R., Vigone, A., Cesaris, M. G. D., Surico, N., Malavasi, F., & Ferrero, E. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1015272401822 · Cited by 88
Arslan, B., Djamgoz, M. B. A., & Akün, E. (2016) · Reviews of Environmental Contamination and Toxicology · doi:10.1007/398_2016_18 · Cited by 88
Guerriero, J. L., Ditsworth, D., Catanzaro, J. M., Sabino, G., Furie, M. B., Kew, R. R., Crawford, H. C., & Zong, W.-X. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003267 · Cited by 87
Shaping the repertoire of tumor‐infiltrating effector and regulatory T cells
Savage, P. A., Leventhal, D. S., & Malchow, S. (2014) · Immunological Reviews · doi:10.1111/imr.12166 · Cited by 87
Freitas, M., & Fernandes, E. G. R. (2011) · Metallomics · doi:10.1039/c1mt00050k · Cited by 87
Gelbard, A. H., Garnett‐Benson, C., Abrams, S. I., Patel, V., Gutkind, J. S., Palena, C., Tsang, K.-Y., Schlom, J., & Hodge, J. W. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1761 · Cited by 87
Autoimmune regulator and self‐tolerance – molecular and clinical aspects
Abramson, J., & Husebye, E. S. (2016) · Immunological Reviews · doi:10.1111/imr.12419 · Cited by 87
Schmidt, M., & Goebeler, M. (2015) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.12673 · Cited by 86
Purinergic signalling in epithelial ion transport: regulation of secretion and absorption
Novak, I. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02225.x · Cited by 86
Enteric neuropathy evoked by repeated cisplatin in the rat: Cisplatin and enteric neuropathy
Vera, G., Castillo, M., Cabezos, P. A., Chiarlone, A., Martín, M. I., Gori, A., Pasquinelli, G., Barbara, G., Stanghellini, V., Corinaldesi, R., et al. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01674.x · Cited by 86
Bamias, A., Tsiatas, M. L., Kafantari, E., Liakou, C. G., Rodolakis, A., Voulgaris, Z., Vlachos, G. D., Papageorgiou, T., Tsitsilonis, O., Bamia, C., et al. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.02.029 · Cited by 86
Frontline Science: Microbiota reconstitution restores intestinal integrity after cisplatin therapy
Perales-Puchalt, A., Perez-Sanz, J., Payne, K. K., Svoronos, N., Allegrezza, M. J., Chaurio, R. A., Anadon, C., Calmette, J., Biswas, S., Mine, J. A., et al. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.5hi1117-446rr · Cited by 86
Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients
Rojkó, L., Reiniger, L., Téglási, V., Fábián, K., Pipek, O., Vágvölgyi, A., Agócs, L., Fillinger, J., Kajdácsi, Z., Tı́már, J., et al. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2642-4 · Cited by 86
Ryan, A. E., Shanahan, F., O’Connell, J., & Houston, A. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1462 · Cited by 86
Enhancing immune responses to tumor-associated antigens
Higgins, J. P., Bernstein, M. B., & Hodge, J. W. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.15.9133 · Cited by 85
Wu, X., Feng, Q., Wang, Y., Shi, J., Ge, H., & Di, W. J. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0749-9 · Cited by 84
Spoerlein-Guettler, C., Mahal, K., Schmidt, H., & Schobert, R. (2013) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2013.07.038 · Cited by 84
Pacini, A., Micheli, L., Maresca, M., Branca, J. J. V., McIntosh, J. M., Ghelardini, C., & Mannelli, L. D. C. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.04.022 · Cited by 84
Zinc Induces Dendritic Cell Tolerogenic Phenotype and Skews Regulatory T Cell–Th17 Balance
George, M. M., Vignesh, K. S., Figueroa, J. A. L., Caruso, J. A., & Deepe, G. S. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600410 · Cited by 84
Mitochondria-Targeting Anticancer Metal Complexes
Erxleben, A. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180307112029 · Cited by 84
Shi, X., Chen, Z., Wang, Y., Guo, Z., & Wang, X. (2018) · Dalton Transactions · doi:10.1039/c8dt00794b · Cited by 84
Kašpárková, J., Farrell, N. P., & Brabec, V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000777200 · Cited by 83
Apoptosis and necroptosis are induced in rainbow trout cell lines exposed to cadmium
Krumschnabel, G., Ebner, H. L., Hess, M. W., & Villunger, A. (2010) · Aquatic Toxicology · doi:10.1016/j.aquatox.2010.04.005 · Cited by 83
Krarup‐Hansen, Rietz, Krarup, Heydorn, Rørth, & Schmalbruch (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00160.x · Cited by 83
Mui, Y. F., Fernández‐Gallardo, J., Elie, B. T., Gubran, A., Maluenda, I., Sanaú, M., Navarro, O., & Contel, M. (2016) · Organometallics · doi:10.1021/acs.organomet.6b00051 · Cited by 83
Fouani, L., Menezes, S. V., Paulson, M., Richardson, D. R., & Kovačević, Ž. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.001 · Cited by 83
T cell receptor repertoire usage in cancer as a surrogate marker for immune responses
Schrama, D., Ritter, C., & Becker, J. C. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-016-0614-9 · Cited by 83
Yang, C., Wang, W., Liang, J., Li, G., Vellaisamy, K., Wong, C., Ma, D., & Leung, C. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00133 · Cited by 83
Kaneko, M., Nozawa, H., Sasaki, K., Hongo, K., Hiyoshi, M., Tada, N., Murono, K., Nirei, T., Kawai, K., Sunami, E., et al. (2012) · Oncology · doi:10.1159/000337228 · Cited by 82
Immunogenic cell death inducers as anticancer agents
Kepp, O., Senovilla, L., & Kroemer, G. (2014) · Oncotarget · doi:10.18632/oncotarget.2266 · Cited by 82
15. IRON AND ITS ROLE IN CANCER DEFENSE: A DOUBLE-EDGED SWORD
Thévenod, F. (2018) · Metallo-Drugs: Development and Action of Anticancer Agents · doi:10.1515/9783110470734-015 · Cited by 82
Ohtsukasa, S., Okabe, S., Yamashita, H., Iwai, T., & Sugihara, K. (2003) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0492-0 · Cited by 81
How Does Ionizing Irradiation Contribute to the Induction of Anti-Tumor Immunity?
Rubner, Y., Wunderlich, R., Rühle, P.-F., Kulzer, L., Werthmöller, N., Frey, B., Weiss, E.-M., Keilholz, L., Fietkau, R., & Gaipl, U. S. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00075 · Cited by 81
B cells and their mediators as targets for therapy in solid tumors
Gunderson, A. J., & Coussens, L. M. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.005 · Cited by 80
The microbiome in anti-cancer therapy
Bashiardes, S., Tuganbaev, T., Federici, S., & Elinav, E. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.04.001 · Cited by 80
González-Pantoja, J. F., Stern, M., Jarzęcki, A. A., Royo, E., Robles‐Escajeda, E., Varela-Ramı́rez, A., Aguilera, R. J., & Contel, M. (2011) · Inorganic Chemistry · doi:10.1021/ic201647h · Cited by 80
Kleinerman, E. S., Zwelling, L. A., & Muchmore, A. V. (1980) · PubMed · Cited by 80
Organometallic Antitumor Compounds: Ferrocifens as Precursors to Quinone Methides
Wang, Y., Pigeon, P., Top, S., McGlinchey, M. J., & Jaouen, G. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201503048 · Cited by 80
Huuskonen, M. T., Tuo, Q., Loppi, S. H., Dhungana, H., Korhonen, P., McInnes, L. E., Donnelly, P. S., Grubman, A., Wojciechowski, S., Lejavová, K., et al. (2017) · Neurotherapeutics · doi:10.1007/s13311-016-0504-9 · Cited by 80
Alkynyl gold(I) complex triggers necroptosis via ROS generation in colorectal carcinoma cells
Mármol, I., Virumbrales-Muñoz, M., Quero, J., Sánchez‐de‐Diego, C., Fernández, L. J., Ochoa, I., Cerrada, E., & Yoldi, M. J. R. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.08.020 · Cited by 80
Presentation and Diagnosis of Hypersensitivity to Platinum Drugs
Caiado, J., & Castells, M. (2015) · Current Allergy and Asthma Reports · doi:10.1007/s11882-015-0515-3 · Cited by 79
Insights into Leukemogenesis from Therapy-Related Leukemia
Pedersen-Bjergaard, J. (2005) · New England Journal of Medicine · doi:10.1056/nejme048336 · Cited by 79
Yeh, K., Wang, H., Chang, J. W. C., Huang, J., Lai, C., Lan, Y., Wu, T., Chang, P., Wang, H., Wu, C., et al. (2013) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2013.01.015 · Cited by 79
Copper Regulates the Canonical NLRP3 Inflammasome
Deigendesch, N., Zychlinsky, A., & Meissner, F. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700712 · Cited by 79
Oh, G., Kim, H., Choi, J.-H., Shen, A., Kim, C.-H., Kim, S., Shin, S., Hong, S., Kim, Y., Park, C., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002183 · Cited by 79
Hao, W., Frei, B. B., Beckman, J. S., & Zhang, W. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01299.2010 · Cited by 79
Montani, M., Pazmay, G. V. B., Hysi, A., Lupidi, G., Pettinari, R., Gambini, V., Tilio, M., Marchetti, F., Pettinari, C., Ferraro, S., et al. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.032 · Cited by 79
Gameiro, S. R., Caballero, J. A., Higgins, J. P., Apelian, D., & Hodge, J. W. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1020-8 · Cited by 78
Outh-Gauer, S., Alt, M., Tourneau, C. L., Augustin, J., Broudin, C., Gasne, C., Denize, T., Mirghani, H., Fabre, E., Ménard, M., et al. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.02.008 · Cited by 78
Kim, N. H., Park, H., Oh, M., & Kim, I. (2013) · BMB Reports · doi:10.5483/bmbrep.2013.46.1.123 · Cited by 78
Increased mutation frequency following treatment with cancer chemotherapy.
Dempsey, J. L., Seshadri, R. S., & Morley, A. A. (1985) · PubMed · Cited by 78
Mayr, J., Heffeter, P., Groza, D., Galvez, L., Koellensperger, G., Roller, A., Alte, B., Haider, M., Berger, W., Kowol, C., et al. (2016) · Chemical Science · doi:10.1039/c6sc03862j · Cited by 78
Self-citationThe Immune Microenvironment: A Major Player in Human Cancers
Fridman, W. H., Remark, R., Goc, J., Giraldo, N. A., Becht, E., Hammond, S. A., Damotte, D., Dieu-Nosjean, M.-C., & Sautès-Fridman, C. (2014) · International Archives of Allergy and Immunology · doi:10.1159/000362332 · Cited by 77
Alteration of a model antigen by Au(III) leads to T cell sensitization to cryptic peptides
Griem, P., Panthel, K., Kalbacher, H., & Gleichmann, E. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260202 · Cited by 77
Innate immune regulation by STAT ‐mediated transcriptional mechanisms
Li, H. S., & Watowich, S. S. (2014) · Immunological Reviews · doi:10.1111/imr.12198 · Cited by 77
Straeten, C. V. D., Quickenborne, D. V., Bart, D. R., Calistri, A., Victor, J. M. K., & Smet, K. D. (2013) · The Bone & Joint Journal · doi:10.1302/0301-620x.95b10.32022 · Cited by 77
Estrov, Z., Manna, S. K., Harris, D., Van, Q., Estey, E. H., Kantarjian, H. M., Talpaz, M., & Aggarwal, B. B. (1999) · Blood · doi:10.1182/blood.v94.8.2844.420k43_2844_2853 · Cited by 77
Kalaycio, M. E., Rybicki, L. A., Pohlman, B. L., Sobecks, R. M., Andresen, S. W., Kuczkowski, E., & Bolwell, B. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.0673 · Cited by 76
Cisplatin ototoxicity involves cytokines and STAT6 signaling network
Kim, H., Oh, G., Lee, J.-H., Lyu, A., Ji, H.-M., Lee, S.-H., Song, J., Park, S.-J., You, Y., Sul, J.-D., et al. (2011) · Cell Research · doi:10.1038/cr.2011.27 · Cited by 76
Why the Immune System Should Be Concerned by Nanomaterials?
Pallardy, M. J., Turbica, I., & Biola-Vidamment, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00544 · Cited by 76
Kim, J. H., Kim, H. S., & Kim, B. J. (2017) · Oncotarget · doi:10.18632/oncotarget.18703 · Cited by 76
In vivo biodistribution of platinum-based drugs encapsulated into multi-walled carbon nanotubes
Li, J., Pant, A., Chin, C. F., Ang, W. H., Ménard‐Moyon, C., Nayak, T. R., Gibson, D., Ramaprabhu, S., Pańczyk, T., Bianco, A., et al. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.01.004 · Cited by 75
Natural Killer Cell Memory: Progress and Implications
Peng, H., & Tian, Z. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01143 · Cited by 75
Wu, L., Yun, Z., Tagawa, T., Rey-McIntyre, K., & de Perrot, M. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-1014 · Cited by 75
Shawish, H. B., Wong, W. Y., Wong, Y. L., Loh, S. W., Looi, C. Y., Hassandarvish, P., Phan, A. Y. L., Wong, W. F., Wang, H., Paterson, I. C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100933 · Cited by 74
Danger signals: Chemotherapy enhancers?
Rivera Vargas, T., & Apetoh, L. (2017) · Immunological Reviews · doi:10.1111/imr.12581 · Cited by 74
Therapeutic potential of the phosphino Cu(I) complex (HydroCuP) in the treatment of solid tumors
Gandin, V., Ceresa, C., Esposito, G., Indraccolo, S., Porchia, M., Tisato, F., Santini, C., Pellei, M., & Marzano, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-13698-1 · Cited by 74
Towards Improved Therapeutic CORMs: Understanding the Reactivity of CORM-3 with Proteins
Santos‐Silva, T., Mukhopadhyay, A., Seixas, J. D., Bernardes, G. J. L., Romão, C. C., & Romão, M. J. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796504583 · Cited by 73
Copper levels in patients with hematological malignancies
Kaiafa, G. D., Saouli, Z., Diamantidis, M. D., Kontoninas, Z., Voulgaridou, V., Raptaki, M., Arampatzi, S., Chatzidimitriou, M., & Perifanis, V. (2012) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2012.07.009 · Cited by 73
Autophagy in natural and therapy-driven anticancer immunosurveillance
Pietrocola, F., Bravo-San Pedro, J. M., Galluzzi, L., & Kroemer, G. (2017) · Autophagy · doi:10.1080/15548627.2017.1310356 · Cited by 73
Chakraborty, M., Wansley, E. K., Carrasquillo, J. A., Yu, S. G., Paik, C. H., Camphausen, K. A., Becker, M. D., Goeckeler, W. F., Schlom, J., & Hodge, J. W. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0335 · Cited by 73
Ugrinova, I., & Pasheva, E. A. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2016.10.001 · Cited by 73
Indoleamine 2,3-dioxygenase as a new target for malignant glioma therapy: Laboratory investigation
Miyazaki, T., Moritake, K., Yamada, K., Hara, N., Osago, H., Shibata, T., Akiyama, Y., & Tsuchiya, M. (2009) · Journal of neurosurgery · doi:10.3171/2008.10.jns081141 · Cited by 72
Tumor‐Targeting of EGFR Inhibitors by Hypoxia‐Mediated Activation
Karnthaler‐Benbakka, C., Groza, D., Kryeziu, K., Pichler, V., Roller, A., Berger, W., Heffeter, P., & Kowol, C. R. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403936 · Cited by 72
Self-citationAnticancer Activity of Methyl-Substituted Oxaliplatin Analogs
Jungwirth, U., Xanthos, D. N., Gojo, J., Bytzek, A. K., Körner, W., Heffeter, P., Abramkin, S. A., Jakupec, M. A., Hartinger, C. G., Windberger, U. B., et al. (2012) · Molecular Pharmacology · doi:10.1124/mol.111.077321 · Cited by 72
Self-citationFong, C. W. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.03.006 · Cited by 72
Grenader, T., Nash, S., Adams, R., Kaplan, R. S., Fisher, D. J., Maughan, T., & Bridgewater, J. A. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.23 · Cited by 72
Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review
Uppendahl, L. D., Dahl, C. M., Miller, J. S., Felices, M., & Geller, M. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01825 · Cited by 72
Positive and Negative Regulation by NK Cells in Cancer
Sungur, C. M., & Murphy, W. J. (2014) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2014010805 · Cited by 71
Intrinsic properties and regulation of Pannexin 1 channel
Chiu, Y., Ravichandran, K. S., & Bayliss, D. A. (2014) · Channels · doi:10.4161/chan.27545 · Cited by 71
TRAIL Triggers Apoptosis in Human Malignant Glioma Cells Through Extrinsic and Intrinsic Pathways
Song, J. H., Song, D. K., Pyrzynska, B., Petruk, K. C., Van Meir, E. G., & Hao, C. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00484.x · Cited by 71
Vanadate Induction of NF-κB Involves IκB Kinase β and SAPK/ERK Kinase 1 in Macrophages
Chen, F., Demers, L. M., Vallyathan, V., Ding, M., Lu, Y., Castranova, V., & Shi, X. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20307 · Cited by 71
Ding, L., Ren, J., Zhang, D., Li, Y., Huang, X., Ji, J., Hu, Q., Wang, H., Ni, Y., & Hou, Y. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0454 · Cited by 71
Kostova, I. P., Momekov, G., & Stancheva, P. (2007) · Metal-Based Drugs · doi:10.1155/2007/15925 · Cited by 70
Research works printed but not linked: 47
- van der Most R. G., 2005, Discovery Medicine, 5, 265
- Alberts B., 2015, Mol. Biol. Cell
- Seliger B., 1996, Exp. Hematol., 24, 1275
- Fink D., 1996, Cancer Res., 56, 4881
- Yoshikawa A., 1997, Kobe J. Med. Sci., 43, 109
- 10.1007/s00775-018- 1546-8 · doi:10.1007/s00775-018-
- Rosenberg, B. In Advances in Antimicrobial and Antineoplastic Chemotherapy, University Park Press: Baltimore, 1972; Vol. 11.
- 10.1002/(SICI)1098-2264(199704)18:4<286::AID-GCC6>3.0.CO;2-X · doi:10.1002/(sici)1098-2264(199704)18:4<286::aid-gcc6>3.0.co;2-x
- Dempsey J. L., 1985, Cancer Res., 45, 2873
- Nio Y., 2000, Anticancer Res., 20, 3293
- Qin X., 2010, Cell. Mol. Biol. (Noisy- le-grand), 56, 1366
- Kleinerman E. S., 1980, Cancer Res., 40, 3099
- Lichtenstein A. K., 1986, Cancer Res., 46, 639
- 10.1002/1097-0142(19930215)71:4<1313::AID-CNCR2820710424>3.0.CO;2-# · doi:10.1002/1097-0142(19930215)71:4<1313::aid-cncr2820710424>3.0.co;2-#
- Yamaue H., 1991, J. Clin. Lab. Immunol., 35, 165
- 10.1002/(SICI)1097-0215(19971104)73:3<416::AID-IJC17>3.0.CO;2-A · doi:10.1002/(sici)1097-0215(19971104)73:3<416::aid-ijc17>3.0.co;2-a
- Jiang J., 2006, Anticancer Res., 26, 2237
- Ujiie T., 1989, Jpn. J. Exp. Med., 59, 17
- Maeda K., 2011, Anticancer Res., 31, 4569
- Miller W. H., 2002, Cancer Res., 62, 3893
- 10.1097/CJI.0b013e3181755deb · DOI
- Kreuser E. D., 1992, Semin. Oncol., 19, 73
- Magnarin M., 2000, Anticancer Res., 20, 2939
- Nardon C., 2014, Anticancer Res., 34, 487
- Hashimoto K., 1994, J. Rheumatol., 21, 1020
- Yan A., 1990, J. Rheumatol., 17, 47
- Wang X. D., 2009, Zhongguo Shi Yan Xue Ye Xue Za Zhi, 17, 533
- 10.1371/journal.pone.0100933 · DOI · Paper page
- Korbecki J., 2012, Acta Biochim. Polym., 59, 195
- 10.3109/1547691X.2014.996681 · DOI
- Desoize B., 2004, Anticancer Res., 24, 1529
- Sava G., 1985, Anticancer Res., 5, 249
- Boscolo P., 2004, Ann. Clin. Lab. Sci., 34, 299
- Brewer G. J., 2000, Clin. Cancer Res., 6, 1
- Redman B. G., 2003, Clin. Cancer Res., 9, 1666
- Pan Q., 2003, Mol. Cancer Res., 1, 701
- Lukasewycz O. A., 1982, J. Natl. Cancer Inst., 69, 489
- 10.1515/9783110470734-016 · doi:10.1515/9783110470734-016
- Eriksson M., 2009, Anticancer Res., 29, 11
- Signat B., 2011, Curr. Issues Mol. Biol., 13, 25
- Sonis S. T., 2004, J. Support. Oncol., 2, 21
- 10.1053/sonc.2002.35524 · doi:10.1053/sonc.2002.35524 · Paper page
- Juhn S. K., 2001, Int. Tinnitus J., 7, 72
- Boussios S., 2012, Ann. Gastroenterol., 25, 106
- Takeyama K., 2000, Int. J. Hematol., 71, 144
- Giles F. J., 1994, Curr. Opin. Hematol., 1, 256
- Lu J., 2017, Ochsner J., 17, 379
Cited by
Metallodrugs are unique: opportunities and challenges of discovery and development
Anthony, E. J., Bolitho, E. M., Bridgewater, H. E., Carter, O. W. L., Donnelly, J. M., Imberti, C., Lant, E. C., Lermyte, F., Needham, R. J., Palau, M., et al. (2020) · Chemical Science · doi:10.1039/d0sc04082g · Cited by 692
Toxicity of gold nanoparticles (AuNPs): A review
Sani, A., Cao, C., & Cui, D. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.100991 · Cited by 454
Classification of Metal-Based Drugs according to Their Mechanisms of Action
Boros, E., Dyson, P. J., & Gasser, G. (2020) · Chem · doi:10.1016/j.chempr.2019.10.013 · Cited by 437
New Designs for Phototherapeutic Transition Metal Complexes
Imberti, C., Zhang, P., Huang, H., & Sadler, P. J. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201905171 · Cited by 443
The immune microenvironment in cartilage injury and repair
Li, M., Yin, H., Yan, Z., Li, H., Wu, J., Wang, Y., Wei, F., Tian, G., Ning, C., Li, H., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.12.006 · Cited by 403
Metadata
- Authors
- Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W.
- Affiliations
- Comprehensive Cancer Center Vienna (AT)
- University of Vienna (AT)
- Corresponding author
- Berger, Walter
- ORCID
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-11-29
- Volume
- 119
- Issue
- 2
- Pages
- 1519-1624
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2903051221
- Cited by
- 355
- References
- 1,298
- Citations by year
- 2026: 28 · 2025: 44 · 2024: 47 · 2023: 51 · 2022: 49 · 2021: 45 · 2020: 53 · 2019: 38
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Chemical Reviews (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
- Funders
- FP7 People: Marie-Curie Actions (609431)
- Universit?t Wien
- Medizinische Universit?t Wien
- Johanna Mahlke, geb. Obermann-Stiftung zur F?rderung der Krebsforschung an der Universit?t Wien
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Keywords
- metal-based anticancer agents, antitumor immunity, immune surveillance, immune evasion, cancer immunotherapy, immune checkpoint inhibitors, tumor microenvironment, innate and adaptive immunity
- MeSH terms
- Gastrointestinal Microbiome, Antineoplastic Agents, Humans, Immunity, Innate, Immunotherapy, Lymphocytes, Metals, Neoplasms, Nanoparticles, Coordination Complexes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.